Merck shares surge anew on lung cancer advance, while Bristol-Myers stock plummets
April 16, 2018 at 11:50 AM EDT
The pairing of Keytruda and chemotherapy reduced risk of death for patients with advanced lung cancer by half, a significant improvement.
